- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07946861
Intramedullary Nailing for Femoral Shaft Fractures
Comparative Effectiveness Randomized Controlled Trial of Micromotion vs Non-micromotion Intramedullary Nailing for Femoral Shaft Fractures
A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Werving
- Indiana University Health Methodist Hospital
-
Hoofdonderzoeker:
- Roman Natoli, MD, PhD
-
Contact:
- Cora F Mizimakoski, Bachelor of Science
- Telefoonnummer: 317-963-5034
- E-mail: cmizimak@iu.edu
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients aged 18-84 years old inclusive with a femoral shaft fracture deemed appropriate for treatment with an IMN by the treating surgeon
Exclusion Criteria:
- Not within age range
- Planned treatment with dominant implants other than IMN
- Non-ambulatory at baseline
- Fracture needs a planned-staged secondary procedure for bone defects (e.g., Masquelet)
- Any previous surgery on the index site
- Fracture fixation >28 days from injury
- Fractures that the treating surgeon indicates require any additional fixation that spans the fracture. These patients will be late ineligible
- Patients with a history of infection or a current active infection at the surgical site
- Patients undergoing revision surgery following primary fixation
- Patients undergoing femoral nailing for a pathological fracture
- Patients undergoing bone transport over an intramedullary nail
- Non-English or Non-Spanish speaking
- Prisoners or impending incarceration
- Patients unwilling or unable to participate in study protocol or follow up in the IU system for 12 months
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Standard Intramedullary Nailing
|
A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals. |
|
Experimenteel: OrthoXel Micromotion Intramedullary Nail
|
An intramedullary nail that allows for controlled axial micromotion. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Tijdsspanne: From enrollment to end of treatment at about a year.
|
Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up. |
From enrollment to end of treatment at about a year.
|
|
Gait balance between the two groups as calculated by the GaitMap.
Tijdsspanne: From enrollment to end of treatment at about a year
|
From enrollment to end of treatment at about a year
|
|
|
Walking speed using a GaitMap
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Modified Radiographic union scores for femoral shaft fractures
Tijdsspanne: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Roman Natoli, MD, PhD, Indiana University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 29753
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .